Skip to main content
logo
Imugene Limited (ASX:IMU)
Australia flag Australia · Delayed Price · Currency is AUD
0.1150
0.00 (0.00%)
May 29, 2026, 4:10 PM AEST

Imugene Revenue

Imugene had revenue of 805.72K AUD in the half year ending December 31, 2025, a decrease of -90.01%. This brings the company's revenue in the last twelve months to 3.94M. In the fiscal year ending June 30, 2025, Imugene had annual revenue of 4.40M, down -11.53%.

Revenue (ttm)
3.94M
Revenue Growth
-11.53%
P/S Ratio
12.12
Revenue / Employee
262.94K
Employees
15
Market Cap
47.82M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20254.40M-573.22K-11.53%
Jun 30, 20244.97M-6.81M-57.80%
Jun 30, 202311.78M-1.19M-9.19%
Jun 30, 202212.97M5.74M79.35%
Jun 30, 20217.23M3.10M74.94%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Botanix Pharmaceuticals21.92M
Radiopharm Theranostics16.28M
Immutep7.92M
Neurizon Therapeutics5.98M
Amplia Therapeutics5.01M
Cynata Therapeutics1.69M
Entropy Neurodynamics1.58M
Avecho Biotechnology1.24M
Revenue Rankings

Imugene News

More News